Colossal Biosciences is advancing its ambitious goal of resurrecting the woolly mammoth by 2028. As proof of their progress, they have genetically modified mice to develop fur similar to that of mammoths. The company's scientists identified mammoth gene versions in mice and used CRISPR technology to edit embryos, according to Chief Scientific Officer Beth Shapiro.
This type of biotechnological advancement demonstrates the potential of technological development across multiple industries, an approach we share at Q2BSTUDIO. We specialize in developing innovative technological solutions and services that drive the digital transformation of companies. Our team works with advanced technologies to deliver customized, efficient products tailored to each client's needs.
Just as Colossal Biosciences uses genetic engineering for innovative projects, at Q2BSTUDIO we apply our knowledge in software development and technological services to help companies improve their processes through disruptive solutions.
